Low-density lipoprotein cholesterol determines oxidative stress and endothelial dysfunction in saphenous veins from patients with coronary artery disease

被引:43
作者
Al-Benna, S
Hamilton, CA
McClure, JD
Rogers, PN
Berg, GA
Ford, I
Delles, C
Dominiczak, AF [1 ]
机构
[1] Univ Glasgow, Div Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow G11 6NT, Lanark, Scotland
[2] Univ Glasgow, Robertson Ctr Biostat, Glasgow G11 6NT, Lanark, Scotland
[3] Western Infirm & Associated Hosp, Dept Cardiothorac Surg, Glasgow, Lanark, Scotland
[4] Gartnavel Royal Hosp, Dept Vasc Surg, Glasgow, Lanark, Scotland
基金
英国惠康基金;
关键词
endothelium; nitric oxide; free radicals; lipids; atherosclerosis;
D O I
10.1161/01.ATV.0000193626.22269.45
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: There is evidence for a relationship between endothelial dysfunction and cardiovascular disease, but a causative role for oxidative stress remains to be determined. Methods and Results: We studied 188 patients with severe coronary artery disease ( CAD), of whom 51 were age and sex matched with 51 healthy controls undergoing varicose vein surgery. Relaxation of saphenous vein to calcium ionophore, apocynin, and allopurinol was studied together with the markers of oxidative stress, total antioxidant capacity and reduced/oxidized glutathione ratio. Vascular superoxide levels were measured using lucigenin chemiluminescence and hydroethidine. Relaxation to calcium ionophore was decreased in CAD compared with control patients ( maximum relaxation 26 +/- 2% versus 60 +/- 1%; P < 0.001). Total superoxide production was increased (0.89 +/- 0.09 versus 0.56 +/- 0.06 nmol/mg per min; P = 0.008), whereas superoxide inhibition with apocynin or allopurinol had a greater effect on vasorelaxation in CAD patients. Low-density lipoprotein (LDL) cholesterol predicted relaxation to calcium ionophore (P < 0.001) and oxidative stress markers (P < 0.001) in CAD patients. Conclusions: Endothelial dysfunction is associated with raised levels of superoxide and biomarkers of oxidative stress in saphenous veins from CAD patients. LDL cholesterol is a major determinant of endothelial dysfunction and oxidative stress in these patients. These results support intensive LDL cholesterol-lowering therapy as suggested by recent clinical trials.
引用
收藏
页码:218 / 223
页数:6
相关论文
共 36 条
  • [1] Alexander RW, 2000, CIRCULATION, V102, P112
  • [2] Investigation into the sources of superoxide in human blood vessels - Angiotensin II increases superoxide production in human internal mammary arteries
    Berry, C
    Hamilton, CA
    Brosnan, J
    Magill, FG
    Berg, GA
    McMurray, JJV
    Dominiczak, AF
    [J]. CIRCULATION, 2000, 101 (18) : 2206 - 2212
  • [3] Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications
    Berry, CE
    Hare, JM
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2004, 555 (03): : 589 - 606
  • [4] The overexpression catalase reduces NO-mediated inhibition of endothelial NO synthase
    Brennan, LA
    Wedgwood, S
    Black, SM
    [J]. IUBMB LIFE, 2002, 54 (05) : 261 - 265
  • [5] Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension
    Butler, R
    Morris, AD
    Belch, JJF
    Hill, A
    Struthers, AD
    [J]. HYPERTENSION, 2000, 35 (03) : 746 - 751
  • [6] The vascular NAD(P)H oxidases as therapeutic targets cardiovascular diseases
    Cai, H
    Griendling, KK
    Harrison, DG
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (09) : 471 - 478
  • [7] gp91phox Contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells
    Chamseddine, AH
    Miller, FJ
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (06): : H2284 - H2289
  • [8] IMPAIRED ENDOTHELIUM-DEPENDENT VASODILATION OF FOREARM RESISTANCE VESSELS IN HYPERCHOLESTEROLEMIA
    CHOWIENCZYK, PJ
    WATTS, GF
    COCKCROFT, JR
    RITTER, JM
    [J]. LANCET, 1992, 340 (8833) : 1430 - 1432
  • [9] Inflammation and endothelial function - Direct vascular effects of human C-reactive protein on nitric oxide bioavailability
    Clapp, BR
    Hirschfield, GM
    Storry, C
    Gallimore, JR
    Stidwill, RP
    Singer, M
    Deanfield, JE
    MacAllister, RJ
    Pepys, MB
    Vallance, P
    Hingorani, AD
    [J]. CIRCULATION, 2005, 111 (12) : 1530 - 1536
  • [10] Endothelial dysfunction: Clinical implications
    Drexler, H
    [J]. PROGRESS IN CARDIOVASCULAR DISEASES, 1997, 39 (04) : 287 - 324